Impact of COVID-19 Infection on the Maternal and Perinatal Outcome of Pregnancies Associated with Preeclampsia

Document Type : Original Article

Authors

Obstetrics and Gynecology Department, Faculty of Medicine, MINIA University, Egypt

Abstract

Objectives: To compare the severity and complications of preeclampsia in the presence and absence of COVID-19 infection
Methods: A cross-sectional study was carried out at Minia Governate isolation Hospitals which have a standard procedure
for monitoring and testing COVID-19. The study enrolled 345 pregnant women after considering eligibility criteria. One
hundred fifteen cases were positive for COVID-19 infection compared with randomly chosen control cases with a ratio of 1:2
of COVID-19-negative pregnant women.
Result: The incidence of preeclampsia in COVID-19-infected pregnant women was 31.3% (36 cases), while 42 cases in the
non-COVID-19 group had preeclampsia with an incidence of 18.3%. There was a high incidence of maternal complications
in the study group (ICU admission incidence was 72.2% versus 45.2%, and maternal mortality was 41.6% versus 38%). Fetal complications were higher in the study group.
Conclusion: The development of preeclampsia in COVID-19 patients is associated with hazardous maternal and fetal
outcomes. It increases the need for ICU admission, invasive ventilation support, maternal and perinatal mortality.

Keywords

Main Subjects

Evidence Based Women's Health Journal
Volume 12, Issue 4
November 2022
Pages 374-377

Files

Share

How to cite

Statistics